[HTML][HTML] Lipid alterations in chronic liver disease and liver cancer

B Paul, M Lewinska, JB Andersen - JHEP reports, 2022 - Elsevier
Lipids are a complex and diverse group of molecules with crucial roles in many
physiological processes, as well as in the onset, progression, and maintenance of cancers …

Physiological and pathological roles of lipogenesis

YG Jeon, YY Kim, G Lee, JB Kim - Nature Metabolism, 2023 - nature.com
Lipids are essential metabolites, which function as energy sources, structural components
and signalling mediators. Most cells are able to convert carbohydrates into fatty acids, which …

The role of PI3K/AKT/mTOR signaling in hepatocellular carcinoma metabolism

LY Tian, DJ Smit, M Jücker - International Journal of Molecular Sciences, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in
the world. Metabolic reprogramming is considered a new hallmark of cancer, but it remains …

Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics

HR Jin, J Wang, ZJ Wang, MJ Xi, BH Xia… - Journal of Hematology & …, 2023 - Springer
Lipid metabolic reprogramming is an emerging hallmark of cancer. In order to sustain
uncontrolled proliferation and survive in unfavorable environments that lack oxygen and …

The multifaceted roles of fatty acid synthesis in cancer

F Röhrig, A Schulze - Nature reviews cancer, 2016 - nature.com
Lipid metabolism, in particular the synthesis of fatty acids (FAs), is an essential cellular
process that converts nutrients into metabolic intermediates for membrane biosynthesis …

USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma

Z Ning, X Guo, X Liu, C Lu, A Wang, X Wang… - Nature …, 2022 - nature.com
Elevated de novo lipogenesis is considered to be a crucial factor in hepatocellular
carcinoma (HCC) development. Herein, we identify ubiquitin-specific protease 22 (USP22) …

[HTML][HTML] mTORC2 promotes tumorigenesis via lipid synthesis

Y Guri, M Colombi, E Dazert, SK Hindupur, J Roszik… - Cancer cell, 2017 - cell.com
Dysregulated mammalian target of rapamycin (mTOR) promotes cancer, but underlying
mechanisms are poorly understood. We describe an mTOR-driven mouse model that …

Metabolic rearrangements in primary liver cancers: cause and consequences

L Satriano, M Lewinska, PM Rodrigues… - Nature reviews …, 2019 - nature.com
Primary liver cancer (PLC) is the fourth most frequent cause of cancer-related death. The
high mortality rates arise from late diagnosis and the limited accuracy of diagnostic and …

Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer

LY Li, Q Yang, YY Jiang, W Yang, Y Jiang, X Li… - Nature …, 2021 - nature.com
Squamous cell carcinomas (SCCs) comprise one of the most common histologic types of
human cancer. Transcriptional dysregulation of SCC cells is orchestrated by tumor protein …

l‐ornithine l‐aspartate in acute treatment of severe hepatic encephalopathy: a double‐blind randomized controlled trial

A Jain, BC Sharma, B Mahajan, S Srivastava… - Hepatology, 2022 - journals.lww.com
Conclusions HBsAg‐positive patients with HCC are at high or intermediate risk of HBV
reactivation depending on the type of HCC therapy. Nucleos (t) ide analogue prophylaxis …